These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 20329581)

  • 21. [Gastroesophageal reflux disease: pathogenetic basis of differentiated tactics of treatment].
    Tkachenko EI; Uspenskiĭ IuP; Karateev AE; Bakulin IG; Pakhomova IG
    Eksp Klin Gastroenterol; 2009; (2):104-14. PubMed ID: 19552028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Proton Pump Inhibitors and their Microbiome-Mediated Side Effects].
    Horvath A; Stadlbauer V
    Zentralbl Chir; 2021 Apr; 146(2):165-169. PubMed ID: 33327006
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Acid suppression therapy: where do we go from here?
    Scarpignato C; Pelosini I; Di Mario F
    Dig Dis; 2006; 24(1-2):11-46. PubMed ID: 16699262
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Editorial: just how "difficult" is it to withdraw PPI treatment?
    Howden CW; Kahrilas PJ
    Am J Gastroenterol; 2010 Jul; 105(7):1538-40. PubMed ID: 20606660
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Safety of Appropriate Use of Over-the-Counter Proton Pump Inhibitors: An Evidence-Based Review and Delphi Consensus.
    Johnson DA; Katz PO; Armstrong D; Cohen H; Delaney BC; Howden CW; Katelaris P; Tutuian RI; Castell DO
    Drugs; 2017 Apr; 77(5):547-561. PubMed ID: 28233274
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation between chronic treatment with proton pump inhibitors and bacterial overgrowth in the stomach: any possible beneficial role for selected lactobacilli?
    Del Piano M; Pagliarulo M; Tari R; Carmagnola S; Balzarini M; Lorenzini P; Pane M
    J Clin Gastroenterol; 2014; 48 Suppl 1():S40-6. PubMed ID: 25291126
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [On-demand treatment with gastric acid inhibitors for gastroesophageal reflux disease].
    Lamers CB
    Ned Tijdschr Geneeskd; 2003 Aug; 147(34):1630-2. PubMed ID: 12966627
    [TBL] [Abstract][Full Text] [Related]  

  • 28. What are the precautions with proton pump inhibitor use for reflux disease?
    Mospan CM
    JAAPA; 2015 Dec; 28(12):23-6. PubMed ID: 26595692
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of proton pump inhibitors in the management of pediatric gastroesophageal reflux disease.
    Tjon JA; Pe M; Soscia J; Mahant S
    Pharmacotherapy; 2013 Sep; 33(9):956-71. PubMed ID: 23712734
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Proton pump inhibitors (PPI): may be not as harmless as believed].
    Reinberg O
    Rev Med Suisse; 2015 Sep; 11(485):1665-71. PubMed ID: 26540997
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-term safety concerns with proton pump inhibitors.
    Ali T; Roberts DN; Tierney WM
    Am J Med; 2009 Oct; 122(10):896-903. PubMed ID: 19786155
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gastric carcinoids after long-term use of a proton pump inhibitor.
    Jianu CS; Fossmark R; Viset T; Qvigstad G; Sørdal O; Mårvik R; Waldum HL
    Aliment Pharmacol Ther; 2012 Oct; 36(7):644-9. PubMed ID: 22861200
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative therapeutic approaches to chronic proton pump inhibitor treatment.
    Fass R
    Clin Gastroenterol Hepatol; 2012 Apr; 10(4):338-45; quiz e39-40. PubMed ID: 22178462
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of long-term PPI treatment on producing bowel symptoms and SIBO.
    Compare D; Pica L; Rocco A; De Giorgi F; Cuomo R; Sarnelli G; Romano M; Nardone G
    Eur J Clin Invest; 2011 Apr; 41(4):380-6. PubMed ID: 21128930
    [TBL] [Abstract][Full Text] [Related]  

  • 35. It is difficult to discontinue PPI treatment in patients with GERD.
    Bjornsson E
    Am J Gastroenterol; 2011 Feb; 106(2):367-8; author reply 368. PubMed ID: 21301460
    [No Abstract]   [Full Text] [Related]  

  • 36. Relative potency of proton-pump inhibitors-comparison of effects on intragastric pH.
    Kirchheiner J; Glatt S; Fuhr U; Klotz U; Meineke I; Seufferlein T; Brockmöller J
    Eur J Clin Pharmacol; 2009 Jan; 65(1):19-31. PubMed ID: 18925391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proton pump inhibitors from clinical pharmacists point of view.
    Pilková A
    Cas Lek Cesk; 2019; 158(7-8):282-288. PubMed ID: 31995994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Proton Pump Inhibitors: The Good, Bad, and Ugly.
    Schnoll-Sussman F; Niec R; Katz PO
    Gastrointest Endosc Clin N Am; 2020 Apr; 30(2):239-251. PubMed ID: 32146944
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Are proton pump inhibitors really so dangerous?
    Savarino V; Dulbecco P; Savarino E
    Dig Liver Dis; 2016 Aug; 48(8):851-9. PubMed ID: 27321544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Acid inhibition and infections outside the gastrointestinal tract.
    Vakil N
    Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S17-20. PubMed ID: 19262541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.